The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Multi-Material 3D Bioprinting Market Research Report 2025
Synopsis
Global Multi-Material 3D Bioprinting market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Multi-Material 3D Bioprinting market research.
Key companies engaged in the Multi-Material 3D Bioprinting industry include Organovo, CELLINK, Aspect Biosystem, Cyfuse Biomedical, TeVido Biodevices, Digilab, Advanced Solutions Life Sciences, Tissue Regeneration Systems and nScrypt, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Multi-Material 3D Bioprinting were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Multi-Material 3D Bioprinting market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multi-Material 3D Bioprinting market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Organovo
CELLINK
Aspect Biosystem
Cyfuse Biomedical
TeVido Biodevices
Digilab
Advanced Solutions Life Sciences
Tissue Regeneration Systems
nScrypt
EnvisionTEC
MedPrin
Nano3D Sciences (n3D)
Rokit
Cellbricks
REGEMAT 3D
Allevi
Poietis
Segment by Type
Extrusion-based Bioprinting
Inkjet-based Bioprinting
Laser-assisted Bioprinting
Others
Segment by Application
Pharmaceutical
Research Institutions
Medical Device
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Multi-Material 3D Bioprinting report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global Multi-Material 3D Bioprinting market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Multi-Material 3D Bioprinting market research.
Key companies engaged in the Multi-Material 3D Bioprinting industry include Organovo, CELLINK, Aspect Biosystem, Cyfuse Biomedical, TeVido Biodevices, Digilab, Advanced Solutions Life Sciences, Tissue Regeneration Systems and nScrypt, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Multi-Material 3D Bioprinting were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Multi-Material 3D Bioprinting market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multi-Material 3D Bioprinting market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Organovo
CELLINK
Aspect Biosystem
Cyfuse Biomedical
TeVido Biodevices
Digilab
Advanced Solutions Life Sciences
Tissue Regeneration Systems
nScrypt
EnvisionTEC
MedPrin
Nano3D Sciences (n3D)
Rokit
Cellbricks
REGEMAT 3D
Allevi
Poietis
Segment by Type
Extrusion-based Bioprinting
Inkjet-based Bioprinting
Laser-assisted Bioprinting
Others
Segment by Application
Pharmaceutical
Research Institutions
Medical Device
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Multi-Material 3D Bioprinting report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multi-Material 3D Bioprinting Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Extrusion-based Bioprinting
1.2.3 Inkjet-based Bioprinting
1.2.4 Laser-assisted Bioprinting
1.2.5 Others
1.3 Market by Application
1.3.1 Global Multi-Material 3D Bioprinting Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Research Institutions
1.3.4 Medical Device
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multi-Material 3D Bioprinting Market Perspective (2018-2029)
2.2 Multi-Material 3D Bioprinting Growth Trends by Region
2.2.1 Global Multi-Material 3D Bioprinting Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multi-Material 3D Bioprinting Historic Market Size by Region (2018-2023)
2.2.3 Multi-Material 3D Bioprinting Forecasted Market Size by Region (2024-2029)
2.3 Multi-Material 3D Bioprinting Market Dynamics
2.3.1 Multi-Material 3D Bioprinting Industry Trends
2.3.2 Multi-Material 3D Bioprinting Market Drivers
2.3.3 Multi-Material 3D Bioprinting Market Challenges
2.3.4 Multi-Material 3D Bioprinting Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multi-Material 3D Bioprinting Players by Revenue
3.1.1 Global Top Multi-Material 3D Bioprinting Players by Revenue (2018-2023)
3.1.2 Global Multi-Material 3D Bioprinting Revenue Market Share by Players (2018-2023)
3.2 Global Multi-Material 3D Bioprinting Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multi-Material 3D Bioprinting Revenue
3.4 Global Multi-Material 3D Bioprinting Market Concentration Ratio
3.4.1 Global Multi-Material 3D Bioprinting Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi-Material 3D Bioprinting Revenue in 2022
3.5 Multi-Material 3D Bioprinting Key Players Head office and Area Served
3.6 Key Players Multi-Material 3D Bioprinting Product Solution and Service
3.7 Date of Enter into Multi-Material 3D Bioprinting Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multi-Material 3D Bioprinting Breakdown Data by Type
4.1 Global Multi-Material 3D Bioprinting Historic Market Size by Type (2018-2023)
4.2 Global Multi-Material 3D Bioprinting Forecasted Market Size by Type (2024-2029)
5 Multi-Material 3D Bioprinting Breakdown Data by Application
5.1 Global Multi-Material 3D Bioprinting Historic Market Size by Application (2018-2023)
5.2 Global Multi-Material 3D Bioprinting Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Multi-Material 3D Bioprinting Market Size (2018-2029)
6.2 North America Multi-Material 3D Bioprinting Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multi-Material 3D Bioprinting Market Size by Country (2018-2023)
6.4 North America Multi-Material 3D Bioprinting Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multi-Material 3D Bioprinting Market Size (2018-2029)
7.2 Europe Multi-Material 3D Bioprinting Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multi-Material 3D Bioprinting Market Size by Country (2018-2023)
7.4 Europe Multi-Material 3D Bioprinting Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multi-Material 3D Bioprinting Market Size (2018-2029)
8.2 Asia-Pacific Multi-Material 3D Bioprinting Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multi-Material 3D Bioprinting Market Size by Region (2018-2023)
8.4 Asia-Pacific Multi-Material 3D Bioprinting Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multi-Material 3D Bioprinting Market Size (2018-2029)
9.2 Latin America Multi-Material 3D Bioprinting Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multi-Material 3D Bioprinting Market Size by Country (2018-2023)
9.4 Latin America Multi-Material 3D Bioprinting Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multi-Material 3D Bioprinting Market Size (2018-2029)
10.2 Middle East & Africa Multi-Material 3D Bioprinting Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multi-Material 3D Bioprinting Market Size by Country (2018-2023)
10.4 Middle East & Africa Multi-Material 3D Bioprinting Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Organovo
11.1.1 Organovo Company Detail
11.1.2 Organovo Business Overview
11.1.3 Organovo Multi-Material 3D Bioprinting Introduction
11.1.4 Organovo Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.1.5 Organovo Recent Development
11.2 CELLINK
11.2.1 CELLINK Company Detail
11.2.2 CELLINK Business Overview
11.2.3 CELLINK Multi-Material 3D Bioprinting Introduction
11.2.4 CELLINK Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.2.5 CELLINK Recent Development
11.3 Aspect Biosystem
11.3.1 Aspect Biosystem Company Detail
11.3.2 Aspect Biosystem Business Overview
11.3.3 Aspect Biosystem Multi-Material 3D Bioprinting Introduction
11.3.4 Aspect Biosystem Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.3.5 Aspect Biosystem Recent Development
11.4 Cyfuse Biomedical
11.4.1 Cyfuse Biomedical Company Detail
11.4.2 Cyfuse Biomedical Business Overview
11.4.3 Cyfuse Biomedical Multi-Material 3D Bioprinting Introduction
11.4.4 Cyfuse Biomedical Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.4.5 Cyfuse Biomedical Recent Development
11.5 TeVido Biodevices
11.5.1 TeVido Biodevices Company Detail
11.5.2 TeVido Biodevices Business Overview
11.5.3 TeVido Biodevices Multi-Material 3D Bioprinting Introduction
11.5.4 TeVido Biodevices Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.5.5 TeVido Biodevices Recent Development
11.6 Digilab
11.6.1 Digilab Company Detail
11.6.2 Digilab Business Overview
11.6.3 Digilab Multi-Material 3D Bioprinting Introduction
11.6.4 Digilab Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.6.5 Digilab Recent Development
11.7 Advanced Solutions Life Sciences
11.7.1 Advanced Solutions Life Sciences Company Detail
11.7.2 Advanced Solutions Life Sciences Business Overview
11.7.3 Advanced Solutions Life Sciences Multi-Material 3D Bioprinting Introduction
11.7.4 Advanced Solutions Life Sciences Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.7.5 Advanced Solutions Life Sciences Recent Development
11.8 Tissue Regeneration Systems
11.8.1 Tissue Regeneration Systems Company Detail
11.8.2 Tissue Regeneration Systems Business Overview
11.8.3 Tissue Regeneration Systems Multi-Material 3D Bioprinting Introduction
11.8.4 Tissue Regeneration Systems Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.8.5 Tissue Regeneration Systems Recent Development
11.9 nScrypt
11.9.1 nScrypt Company Detail
11.9.2 nScrypt Business Overview
11.9.3 nScrypt Multi-Material 3D Bioprinting Introduction
11.9.4 nScrypt Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.9.5 nScrypt Recent Development
11.10 EnvisionTEC
11.10.1 EnvisionTEC Company Detail
11.10.2 EnvisionTEC Business Overview
11.10.3 EnvisionTEC Multi-Material 3D Bioprinting Introduction
11.10.4 EnvisionTEC Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.10.5 EnvisionTEC Recent Development
11.11 MedPrin
11.11.1 MedPrin Company Detail
11.11.2 MedPrin Business Overview
11.11.3 MedPrin Multi-Material 3D Bioprinting Introduction
11.11.4 MedPrin Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.11.5 MedPrin Recent Development
11.12 Nano3D Sciences (n3D)
11.12.1 Nano3D Sciences (n3D) Company Detail
11.12.2 Nano3D Sciences (n3D) Business Overview
11.12.3 Nano3D Sciences (n3D) Multi-Material 3D Bioprinting Introduction
11.12.4 Nano3D Sciences (n3D) Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.12.5 Nano3D Sciences (n3D) Recent Development
11.13 Rokit
11.13.1 Rokit Company Detail
11.13.2 Rokit Business Overview
11.13.3 Rokit Multi-Material 3D Bioprinting Introduction
11.13.4 Rokit Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.13.5 Rokit Recent Development
11.14 Cellbricks
11.14.1 Cellbricks Company Detail
11.14.2 Cellbricks Business Overview
11.14.3 Cellbricks Multi-Material 3D Bioprinting Introduction
11.14.4 Cellbricks Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.14.5 Cellbricks Recent Development
11.15 REGEMAT 3D
11.15.1 REGEMAT 3D Company Detail
11.15.2 REGEMAT 3D Business Overview
11.15.3 REGEMAT 3D Multi-Material 3D Bioprinting Introduction
11.15.4 REGEMAT 3D Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.15.5 REGEMAT 3D Recent Development
11.16 Allevi
11.16.1 Allevi Company Detail
11.16.2 Allevi Business Overview
11.16.3 Allevi Multi-Material 3D Bioprinting Introduction
11.16.4 Allevi Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.16.5 Allevi Recent Development
11.17 Poietis
11.17.1 Poietis Company Detail
11.17.2 Poietis Business Overview
11.17.3 Poietis Multi-Material 3D Bioprinting Introduction
11.17.4 Poietis Revenue in Multi-Material 3D Bioprinting Business (2018-2023)
11.17.5 Poietis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
